Skip to content

Clinical trials

Phase 3 Sleep Apnea, Obstructive trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sleep Apnea, Obstructive Phase: Phase 3 Country / region: Australia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20091
20111
20221
20232
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Active, not recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Amgen2
Novo Nordisk A/S2
Adelaide Institute for Sleep Health1
Apnex Medical, Inc.1
Cephalon1
McMaster University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sleep Apnea, Obstructive12
Obesity8
Overweight6
Apnea2
Sleep Apnea Syndromes2
Cardiovascular Diseases1
Diabetes Mellitus, Type 21
Disorders of Excessive Somnolence1
Narcolepsy1
Osteoarthritis, Knee1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.